274 related articles for article (PubMed ID: 7500097)
1. Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.
Sheean GL; Lees AJ
J Neurol Neurosurg Psychiatry; 1995 Dec; 59(6):601-7. PubMed ID: 7500097
[TBL] [Abstract][Full Text] [Related]
2. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A.
Houser MK; Sheean GL; Lees AJ
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):577-80. PubMed ID: 9598669
[TBL] [Abstract][Full Text] [Related]
3. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
Sloop RR; Cole D; Patel MC
Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
[TBL] [Abstract][Full Text] [Related]
4. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
5. Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients.
Poewe W; Schelosky L; Kleedorfer B; Heinen F; Wagner M; Deuschl G
J Neurol; 1992 Jan; 239(1):21-5. PubMed ID: 1541964
[TBL] [Abstract][Full Text] [Related]
6. Development of resistance to botulinum toxin type A in patients with torticollis.
Greene P; Fahn S; Diamond B
Mov Disord; 1994 Mar; 9(2):213-7. PubMed ID: 8196686
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin for the treatment of cervical dystonia.
Tintner R; Jankovic J
Expert Opin Pharmacother; 2001 Dec; 2(12):1985-94. PubMed ID: 11825330
[TBL] [Abstract][Full Text] [Related]
8. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A.
Greene PE; Fahn S
Mov Disord; 1993 Oct; 8(4):479-83. PubMed ID: 8232357
[TBL] [Abstract][Full Text] [Related]
9. Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
Ford B; Louis ED; Greene P; Fahn S
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):472-8. PubMed ID: 9771768
[TBL] [Abstract][Full Text] [Related]
10. Age-related botulinum toxin effects on muscle fiber conduction velocity in non-injected muscles.
Lange F; van Weerden TW; van der Hoeven JH
Clin Neurophysiol; 2007 Nov; 118(11):2398-403. PubMed ID: 17897878
[TBL] [Abstract][Full Text] [Related]
11. [Electromyography monitoring in the treatment of torticollis with botulinum toxin].
Domzał TM; Tutaj A
Pol Merkur Lekarski; 2000 Jul; 8(49):474-5. PubMed ID: 11070717
[TBL] [Abstract][Full Text] [Related]
12. [The clinical usefulness of botulinum toxin type A for spasmodic torticollis and facial spasm].
Mezaki T; Kaji R; Kimura J; Osame M; Mizuno Y; Hirayama K; Maruyama S; Iwata M; Kanazawa I; Kinoshita M
No To Shinkei; 1995 Aug; 47(8):749-54. PubMed ID: 7546919
[TBL] [Abstract][Full Text] [Related]
13. An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment.
Alfonsi E; Merlo IM; Ponzio M; Montomoli C; Tassorelli C; Biancardi C; Lozza A; Martignoni E
J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):54-60. PubMed ID: 19762326
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
Cardoso F
Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cervical dystonia with botulinum toxin.
Jankovic J
Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
[TBL] [Abstract][Full Text] [Related]
16. Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients.
Greene PE; Fahn S
Mov Disord; 1996 Mar; 11(2):181-4. PubMed ID: 8684389
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and management of antibody-induced failure of botulinum toxin therapy.
Dressler D
Mov Disord; 2004 Mar; 19 Suppl 8():S92-S100. PubMed ID: 15027060
[TBL] [Abstract][Full Text] [Related]
18. Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.
Jankovic J; Hunter C; Dolimbek BZ; Dolimbek GS; Adler CH; Brashear A; Comella CL; Gordon M; Riley DE; Sethi K; Singer C; Stacy M; Tarsy D; Atassi MZ
Neurology; 2006 Dec; 67(12):2233-5. PubMed ID: 17190952
[TBL] [Abstract][Full Text] [Related]
19. Ptosis as a remote effect of therapeutic botulinum toxin B injection.
Racette BA; Lopate G; Good L; Sagitto S; Perlmutter JS
Neurology; 2002 Nov; 59(9):1445-7. PubMed ID: 12427903
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia.
Berman B; Seeberger L; Kumar R
Mov Disord; 2005 Feb; 20(2):233-7. PubMed ID: 15455449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
